Ignite Creation Date:
2025-12-26 @ 10:32 AM
Ignite Modification Date:
2026-02-24 @ 12:14 AM
Study NCT ID:
NCT04097028
Status:
COMPLETED
Last Update Posted:
2025-04-29
First Post:
2019-09-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Use of Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy for the Treatment of Resectable Esophageal or Gastroesophageal Junction (GEJ) Adenocarcinoma
Sponsor:
Roswell Park Cancer Institute
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12-20
Start Date Type:
ACTUAL
Primary Completion Date:
2022-12-16
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-02-05
Completion Date Type:
ACTUAL
First Submit Date:
2019-09-18
First Submit QC Date:
None
Study First Post Date:
2019-09-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-11-21
Results First Submit QC Date:
None
Results First Post Date:
2024-01-18
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-23
Last Update Post Date:
2025-04-29
Last Update Post Date Type:
ACTUAL